EXV4.DE vs. NBTK.DE
EXV4.DE (iShares STOXX Europe 600 Health Care UCITS ETF (DE)) and NBTK.DE (Invesco Nasdaq Biotech UCITS ETF) are both Health & Biotech Equities funds - EXV4.DE tracks the STOXX® Europe 600 Health Care while NBTK.DE tracks the Nasdaq Biotechnology. Both are passively managed. Over the past 5 years, EXV4.DE returned 4.98%/yr vs 5.63%/yr for NBTK.DE. A 0.57 correlation means they provide meaningful diversification when combined. EXV4.DE charges 0.46%/yr vs 0.40%/yr for NBTK.DE.
Performance
EXV4.DE vs. NBTK.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EXV4.DE achieves a -2.60% return, which is significantly lower than NBTK.DE's 4.27% return.
EXV4.DE
- 1D
- 2.82%
- 1M
- 0.11%
- YTD
- -2.60%
- 6M
- -1.19%
- 1Y
- 4.38%
- 3Y*
- 2.32%
- 5Y*
- 4.98%
- 10Y*
- 5.78%
NBTK.DE
- 1D
- 2.92%
- 1M
- 0.38%
- YTD
- 4.27%
- 6M
- 3.76%
- 1Y
- 39.20%
- 3Y*
- 9.94%
- 5Y*
- 5.63%
- 10Y*
- —
EXV4.DE vs. NBTK.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
EXV4.DE iShares STOXX Europe 600 Health Care UCITS ETF (DE) | -2.60% | 7.23% | 3.85% | 7.52% | -6.10% | 25.12% | -2.48% | 10.34% |
NBTK.DE Invesco Nasdaq Biotech UCITS ETF | 4.27% | 18.60% | 4.57% | 2.51% | -6.11% | 7.46% | 14.59% | 17.24% |
Correlation
The correlation between EXV4.DE and NBTK.DE is 0.58, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.58 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.53 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.54 |
Correlation (All Time) Calculated using the full available price history since Oct 22, 2019 | 0.57 |
The correlation between EXV4.DE and NBTK.DE has been stable across timeframes, ranging from 0.53 to 0.58 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EXV4.DE vs. NBTK.DE — Risk / Return Rank
EXV4.DE
NBTK.DE
EXV4.DE vs. NBTK.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares STOXX Europe 600 Health Care UCITS ETF (DE) (EXV4.DE) and Invesco Nasdaq Biotech UCITS ETF (NBTK.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EXV4.DE | NBTK.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.74 | ||
| Sortino ratioReturn per unit of downside risk | -2.32 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.34 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | 0.38 | 6.16 | -5.78 |
| Martin ratioReturn relative to average drawdown | 0.84 | 17.06 | -16.21 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| EXV4.DE | NBTK.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.29 | 2.03 | -1.74 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.32 | 0.27 | +0.04 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.37 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | 0.42 | -0.10 |
Drawdowns
EXV4.DE vs. NBTK.DE - Drawdown Comparison
The maximum EXV4.DE drawdown since its inception was -44.54%, which is greater than NBTK.DE's maximum drawdown of -30.99%. Use the drawdown chart below to compare losses from any high point for EXV4.DE and NBTK.DE.
Loading charts...
Drawdown Indicators
| EXV4.DE | NBTK.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.54% | -30.99% | -13.55% |
Max Drawdown (1Y)Largest decline over 1 year | -12.57% | -6.24% | -6.33% |
Max Drawdown (3Y)Largest decline over 3 years | -26.55% | -29.35% | +2.80% |
Max Drawdown (5Y)Largest decline over 5 years | -26.55% | -30.99% | +4.44% |
Max Drawdown (10Y)Largest decline over 10 years | -26.55% | — | — |
Current DrawdownCurrent decline from peak | -11.65% | -1.44% | -10.21% |
Average DrawdownAverage peak-to-trough decline | -11.17% | -10.62% | -0.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.72% | 2.26% | +3.46% |
Volatility
EXV4.DE vs. NBTK.DE - Volatility Comparison
The current volatility for iShares STOXX Europe 600 Health Care UCITS ETF (DE) (EXV4.DE) is 5.58%, while Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) has a volatility of 6.41%. This indicates that EXV4.DE experiences smaller price fluctuations and is considered to be less risky than NBTK.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EXV4.DE | NBTK.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.58% | 6.41% | -0.83% |
Volatility (6M)Calculated over the trailing 6-month period | 11.86% | 14.11% | -2.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.68% | 19.00% | -2.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.55% | 20.30% | -4.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.74% | 22.05% | -6.31% |
EXV4.DE vs. NBTK.DE - Expense Ratio Comparison
EXV4.DE has a 0.46% expense ratio, which is higher than NBTK.DE's 0.40% expense ratio.
Dividends
EXV4.DE vs. NBTK.DE - Dividend Comparison
EXV4.DE's dividend yield for the trailing twelve months is around 1.61%, while NBTK.DE has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EXV4.DE iShares STOXX Europe 600 Health Care UCITS ETF (DE) | 1.61% | 1.58% | 1.45% | 1.60% | 1.59% | 1.47% | 1.24% | 1.79% | 1.85% | 2.64% | 2.90% | 2.60% |
NBTK.DE Invesco Nasdaq Biotech UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
EXV4.DE and NBTK.DE have a correlation of 0.58, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, NBTK.DE is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.
NBTK.DE is cheaper with a 0.40% expense ratio, compared with 0.46% for EXV4.DE.
EXV4.DE tracks STOXX® Europe 600 Health Care, while NBTK.DE tracks Nasdaq Biotechnology. They also come from different issuers: iShares and Invesco. Their fees differ too: 0.46% for EXV4.DE and 0.40% for NBTK.DE.
Find the right allocation for EXV4.DE and NBTK.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer